Allison D Rosen, Sae Takada, Catherine Juillard, Yulsi L Fernandez Montero, Amy M Richards, Serge Ngekeng, Steven J Shoptaw, Michelle A Bholat
{"title":"揭示药物使用障碍与30天意外再入院之间的联系。","authors":"Allison D Rosen, Sae Takada, Catherine Juillard, Yulsi L Fernandez Montero, Amy M Richards, Serge Ngekeng, Steven J Shoptaw, Michelle A Bholat","doi":"10.1111/add.70136","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30-day unplanned readmissions, a marker of quality of care. This study aimed to measure the association between substance use disorder diagnoses, discharge disposition and 30-day unplanned hospital readmissions.</p><p><strong>Design: </strong>This retrospective cohort study extracted data from electronic health records of all inpatients. The index admission was defined as a patient's first admission in 2022.</p><p><strong>Setting: </strong>Two urban, academic medical centers in Los Angeles, California, USA.</p><p><strong>Participants: </strong>Among 22 108 inpatients aged 18 and over and who did not expire during the hospital stay, 7.4% had at least one substance use disorder. The median age was 58, and 56.1% identified as female. Most patients identified as white (43.3%), followed by 22.5% Hispanic/Latinx, 10.8% Asian and 9.1% Black; 14.3% identified as another race.</p><p><strong>Measurements: </strong>The exposure was diagnosis of any substance use disorder at index admission. The outcome was 30-day unplanned readmission.</p><p><strong>Findings: </strong>Patients with any substance use disorder [adjusted risk ratio (aRR) = 1.24, 95% confidence interval (CI) = 1.05-1.45) and patients specifically with opioid use disorder (aRR = 1.40, 95% CI = 1.09-1.80) were more likely to have a 30-day unplanned readmission compared with patients without substance use disorders. When assessing an interaction with discharge disposition, the association only held for patients discharged to home/self-care (aRR = 1.33, 95% CI = 1.05-1.69). Among patients who had zero, one, two and three or more unplanned readmissions, 7.1%, 8.8%, 14.0% and 15.5% had a substance use disorder at their index admission, respectively (P < 0.001).</p><p><strong>Conclusions: </strong>In the United States, hospital patients with substance use disorder diagnoses appear to have a higher risk of 30-day unplanned readmission to hospital and account for a disproportionate share of patients who have multiple unplanned readmissions than hospital patients without substance use disorder diagnoses.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unpacking the link between substance use disorders and 30-day unplanned readmission.\",\"authors\":\"Allison D Rosen, Sae Takada, Catherine Juillard, Yulsi L Fernandez Montero, Amy M Richards, Serge Ngekeng, Steven J Shoptaw, Michelle A Bholat\",\"doi\":\"10.1111/add.70136\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30-day unplanned readmissions, a marker of quality of care. This study aimed to measure the association between substance use disorder diagnoses, discharge disposition and 30-day unplanned hospital readmissions.</p><p><strong>Design: </strong>This retrospective cohort study extracted data from electronic health records of all inpatients. The index admission was defined as a patient's first admission in 2022.</p><p><strong>Setting: </strong>Two urban, academic medical centers in Los Angeles, California, USA.</p><p><strong>Participants: </strong>Among 22 108 inpatients aged 18 and over and who did not expire during the hospital stay, 7.4% had at least one substance use disorder. The median age was 58, and 56.1% identified as female. Most patients identified as white (43.3%), followed by 22.5% Hispanic/Latinx, 10.8% Asian and 9.1% Black; 14.3% identified as another race.</p><p><strong>Measurements: </strong>The exposure was diagnosis of any substance use disorder at index admission. The outcome was 30-day unplanned readmission.</p><p><strong>Findings: </strong>Patients with any substance use disorder [adjusted risk ratio (aRR) = 1.24, 95% confidence interval (CI) = 1.05-1.45) and patients specifically with opioid use disorder (aRR = 1.40, 95% CI = 1.09-1.80) were more likely to have a 30-day unplanned readmission compared with patients without substance use disorders. When assessing an interaction with discharge disposition, the association only held for patients discharged to home/self-care (aRR = 1.33, 95% CI = 1.05-1.69). Among patients who had zero, one, two and three or more unplanned readmissions, 7.1%, 8.8%, 14.0% and 15.5% had a substance use disorder at their index admission, respectively (P < 0.001).</p><p><strong>Conclusions: </strong>In the United States, hospital patients with substance use disorder diagnoses appear to have a higher risk of 30-day unplanned readmission to hospital and account for a disproportionate share of patients who have multiple unplanned readmissions than hospital patients without substance use disorder diagnoses.</p>\",\"PeriodicalId\":109,\"journal\":{\"name\":\"Addiction\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Addiction\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/add.70136\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/add.70136","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:在过去十年中,美国药物使用障碍的患病率增加了两倍以上,预计更多的住院患者被诊断为药物使用障碍,因此有必要评估与30天计划外再入院的潜在联系,这是护理质量的一个标志。本研究旨在测量药物使用障碍诊断、出院处置和30天计划外再入院之间的关系。设计:本回顾性队列研究从所有住院患者的电子健康记录中提取数据。索引入院定义为患者于2022年首次入院。地点:美国加利福尼亚州洛杉矶的两个城市学术医疗中心。参与者:在22 108名18岁及以上且住院期间未死亡的住院患者中,7.4%至少有一种物质使用障碍。中位年龄为58岁,56.1%为女性。大多数患者为白人(43.3%),其次是22.5%的西班牙裔/拉丁裔,10.8%的亚洲人和9.1%的黑人;14.3%被认定为另一个种族。测量:暴露是在入院时诊断为任何物质使用障碍。结果是30天的意外再入院。结果:任何物质使用障碍的患者[调整风险比(aRR) = 1.24, 95%可信区间(CI) = 1.05-1.45]和阿片类药物使用障碍的患者(aRR = 1.40, 95% CI = 1.09-1.80)与无物质使用障碍的患者相比,更有可能出现30天的计划外再入院。当评估与出院处置的相互作用时,该关联仅适用于出院回家/自我护理的患者(aRR = 1.33, 95% CI = 1.05-1.69)。在计划外再入院0次、1次、2次和3次及以上的患者中,分别有7.1%、8.8%、14.0%和15.5%的患者在首次入院时存在物质使用障碍(P结论:在美国,被诊断为物质使用障碍的住院患者似乎在30天内计划外再入院的风险更高,与没有被诊断为物质使用障碍的住院患者相比,多次计划外再入院的患者所占比例不成比例。
Unpacking the link between substance use disorders and 30-day unplanned readmission.
Background and aims: Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30-day unplanned readmissions, a marker of quality of care. This study aimed to measure the association between substance use disorder diagnoses, discharge disposition and 30-day unplanned hospital readmissions.
Design: This retrospective cohort study extracted data from electronic health records of all inpatients. The index admission was defined as a patient's first admission in 2022.
Setting: Two urban, academic medical centers in Los Angeles, California, USA.
Participants: Among 22 108 inpatients aged 18 and over and who did not expire during the hospital stay, 7.4% had at least one substance use disorder. The median age was 58, and 56.1% identified as female. Most patients identified as white (43.3%), followed by 22.5% Hispanic/Latinx, 10.8% Asian and 9.1% Black; 14.3% identified as another race.
Measurements: The exposure was diagnosis of any substance use disorder at index admission. The outcome was 30-day unplanned readmission.
Findings: Patients with any substance use disorder [adjusted risk ratio (aRR) = 1.24, 95% confidence interval (CI) = 1.05-1.45) and patients specifically with opioid use disorder (aRR = 1.40, 95% CI = 1.09-1.80) were more likely to have a 30-day unplanned readmission compared with patients without substance use disorders. When assessing an interaction with discharge disposition, the association only held for patients discharged to home/self-care (aRR = 1.33, 95% CI = 1.05-1.69). Among patients who had zero, one, two and three or more unplanned readmissions, 7.1%, 8.8%, 14.0% and 15.5% had a substance use disorder at their index admission, respectively (P < 0.001).
Conclusions: In the United States, hospital patients with substance use disorder diagnoses appear to have a higher risk of 30-day unplanned readmission to hospital and account for a disproportionate share of patients who have multiple unplanned readmissions than hospital patients without substance use disorder diagnoses.
期刊介绍:
Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines.
Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries.
Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.